208 related articles for article (PubMed ID: 32699529)
1. Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis.
Zhang J; Zhang J; Yuan C; Luo Y; Li Y; Dai P; Sun W; Zhang N; Ren J; Zhang J; Gong Y; Xie C
Cancer Cell Int; 2020; 20():330. PubMed ID: 32699529
[TBL] [Abstract][Full Text] [Related]
2. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
[TBL] [Abstract][Full Text] [Related]
3. Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma.
Li L; Yu X; Ma G; Ji Z; Bao S; He X; Song L; Yu Y; Shi M; Liu X
Int J Gen Med; 2021; 14():9007-9022. PubMed ID: 34876838
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q
Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696
[No Abstract] [Full Text] [Related]
5. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.
Li N; Jia W; Wang J; Shao Q; Feng X; Li Z; Sun W; Kang M; Hu D; Xing L; Zhan X
EPMA J; 2024 Jun; 15(2):345-373. PubMed ID: 38841624
[TBL] [Abstract][Full Text] [Related]
6. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z
Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ
Front Oncol; 2020; 10():1588. PubMed ID: 33014809
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma.
Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H
Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Two-Gene Immunogenomic-Related Prognostic Signature in Lung Squamous Cell Carcinoma.
Zhang X; Xiao J; Fu X; Qin G; Yu M; Chen G; Li X
Front Mol Biosci; 2022; 9():867494. PubMed ID: 35463955
[TBL] [Abstract][Full Text] [Related]
10. Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer.
Zhuang Y; Li S; Liu C; Li G
Front Oncol; 2021; 11():546455. PubMed ID: 33747902
[No Abstract] [Full Text] [Related]
11. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
[TBL] [Abstract][Full Text] [Related]
12. A novel immunogenomic prognostic signature in lung squamous carcinoma.
Hou J; Zhong Q
Medicine (Baltimore); 2021 Jan; 100(2):e24073. PubMed ID: 33466167
[TBL] [Abstract][Full Text] [Related]
13. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma.
Zhai WY; Duan FF; Chen S; Wang JY; Zhao ZR; Wang YZ; Rao BY; Lin YB; Long H
Front Cell Dev Biol; 2022; 10():770550. PubMed ID: 35300428
[TBL] [Abstract][Full Text] [Related]
14. Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.
Lin P; Guo YN; Shi L; Li XJ; Yang H; He Y; Li Q; Dang YW; Wei KL; Chen G
Aging (Albany NY); 2019 Jan; 11(2):480-500. PubMed ID: 30661062
[TBL] [Abstract][Full Text] [Related]
15. Establishment of the Prognostic Index Reflecting Tumor Immune Microenvironment of Lung Adenocarcinoma Based on Metabolism-Related Genes.
Zhang J; Zhang J; Yuan C; Luo Y; Li Y; Dai P; Sun W; Zhang N; Ren J; Zhang J; Gong Y; Xie C
J Cancer; 2020; 11(24):7101-7115. PubMed ID: 33193873
[No Abstract] [Full Text] [Related]
16. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
Front Oncol; 2020; 10():541330. PubMed ID: 33072571
[No Abstract] [Full Text] [Related]
17. Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma.
Ren S; Wang W; Shen H; Zhang C; Hao H; Sun M; Wang Y; Zhang X; Lu B; Chen C; Wang Z
Front Oncol; 2020; 10():1496. PubMed ID: 32983989
[No Abstract] [Full Text] [Related]
18. Development of a prognostic index of colon adenocarcinoma based on immunogenomic landscape analysis.
Qiang W; Dai Y; Sun G; Xing X; Sun X
Ann Transl Med; 2020 Mar; 8(6):284. PubMed ID: 32355728
[TBL] [Abstract][Full Text] [Related]
19. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
[TBL] [Abstract][Full Text] [Related]
20. Development of a Clinical Prognostic Model for Metabolism-Related Genes in Squamous Lung Cancer and Correlation Analysis of Immune Microenvironment.
Zhuang Z; Gao C
Biomed Res Int; 2022; 2022():6962056. PubMed ID: 36110123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
